The trouble for the healthcare revenue cycle management company began when it filed a notification of late filing for its 2025 fiscal year. TruBridge management admitted to identifying significant errors in previously issued financial statements covering 2023 and 2024, as well as multiple quarters in 2025. These discrepancies involve complex accounting areas, specifically revenue recognition, contract costs, stock-based compensation, and capitalized software development expenses.

Following the revelation that these financial records required major revisions, the company's shares fell $1.84 to close at $15.75. The Rosen Law Firm is now seeking to represent investors who suffered losses during this period, operating on a contingency fee basis. Shareholders looking to join the prospective class action are directed to contact Phillip Kim at the firm's New York offices to discuss potential recovery options.